Drug Profile
Research programme: diabetes therapy - Biovitrum
Alternative Names: BVT 24834; BVT 3776; Diabetes therapy research programme - BiovitrumLatest Information Update: 08 Sep 2005
Price :
$50
*
At a glance
- Originator Biovitrum
- Class
- Mechanism of Action Fatty acid-binding protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 08 Sep 2005 Discontinued - Preclinical for Type-2 diabetes mellitus in Sweden (unspecified route)
- 07 Sep 2004 Preclinical trials in Type-2 diabetes mellitus in Sweden (unspecified route)